Insider Transactions in Q1 2023 at Mineralys Therapeutics, Inc. (MLYS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2023
|
Hbm Healthcare Investments (Cayman) Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
312,500
+8.85%
|
$5,000,000
$16.0 P/Share
|
|
Feb 14
2023
|
Hbm Healthcare Investments (Cayman) Ltd. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,905,606
+37.46%
|
-
|
|
Feb 14
2023
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,250,000
+26.31%
|
$20,000,000
$16.0 P/Share
|
|
Feb 14
2023
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
1,928,476
+50.0%
|
-
|
|
Feb 14
2023
|
Srinivas Akkaraju Director |
BUY
Open market or private purchase
|
Indirect |
937,500
+17.18%
|
$15,000,000
$16.0 P/Share
|
|
Feb 14
2023
|
Srinivas Akkaraju Director |
BUY
Conversion of derivative security
|
Indirect |
3,581,861
+50.0%
|
-
|
|
Feb 14
2023
|
Adam Scott Levy CFO and Secretary |
BUY
Open market or private purchase
|
Direct |
6,250
+1.75%
|
$100,000
$16.0 P/Share
|
|
Feb 14
2023
|
Brian Taylor Slingsby Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+2.65%
|
$4,000,000
$16.0 P/Share
|
|
Feb 14
2023
|
Brian Taylor Slingsby Director |
BUY
Conversion of derivative security
|
Indirect |
4,314,093
+32.54%
|
-
|